Medication info
Simvastatin/Ezetimibe Tablets 10/20

Simvastatin/Ezetimibe Tablets 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
VivaZon Pharmaceutical Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablets
Packaging
30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu * 3)
Approval status
Active

MFDS item code 201604540 · Approved 2016.07.22 · Insurance code 658203370

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. This drug is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. Patients requiring less reduction in LDL-cholesterol may start with 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks before adjusting the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapy is not useful. Use in patients with hepatic impairment Dose adjustment is not necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease Dose adjustment is not necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and carefully monitor these patients when administering this drug at higher doses (see Precautions for Use, 5. General Precautions). Use in older adults Dose adjustment is not necessary in older adults. Concomitant administration with other drugs (See Precautions for Use, 6. Interactions) Administer this drug at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
VivaZon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to diet to decrease total cholesterol, LDL cholesterol, Apo B, and triglycerides in patients with primary hypercholesterolemia, particularly those with heterozygous familial and non-familial cases, while increasing HDL cholesterol. It also helps lower blood cholesterol levels in patients with homozygous familial hypercholesterolemia when used in conjunction with or as an alternative to other lipid-lowering treatments. This medication safely and effectively helps manage lipids in patients at increased risk of atherosclerotic vascular disease due to hypercholesterolemia. It should be used in conjunction with an appropriate diet, and any secondary causes from other diseases or medications must be identified and managed first. Tests including total cholesterol, LDL, HDL, and triglycerides should be performed to accurately evaluate lipid levels, and additional tests may be necessary if triglycerides are extremely high. This medication contributes to improving cholesterol levels and maintaining vascular health in conjunction with a proper diet.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. This drug is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. Patients requiring less reduction in LDL-cholesterol may start with 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks before adjusting the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapy is not useful. Use in patients with hepatic impairment Dose adjustment is not necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease Dose adjustment is not necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and carefully monitor these patients when administering this drug at higher doses (see Precautions for Use, 5. General Precautions). Use in older adults Dose adjustment is not necessary in older adults. Concomitant administration with other drugs (See Precautions for Use, 6. Interactions) Administer this drug at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication is primarily used to lower blood cholesterol levels. Caution is needed as muscle-related symptoms may occur during treatment. If muscle pain or weakness develops, you should inform your doctor immediately. Patients with compromised liver function or active liver disease should not take this medication. Women who are pregnant or breastfeeding should not use this medication and should consult prior to taking it if planning to become pregnant. This medication may increase the risk of muscle damage if taken with certain drugs, so if you are on other medications, you must consult with your doctor or pharmacist. Particular caution is required when combined with strong liver enzyme inhibitors, some antibiotics, antiviral agents, immunosuppressants, and treatments for heart disease. Elderly patients or those with impaired kidney function should be more vigilant for muscle-related symptoms when taking this medication. It is advisable to regularly conduct blood tests to monitor liver function and muscle status while on this medication. During treatment, it is safer to avoid specific foods such as grapefruit juice. Additionally, this medication may raise blood sugar levels in some patients, so individuals at risk for diabetes should be attentive to blood sugar management. In the case of overdose, there is no specific antidote, and you should seek appropriate treatment at a hospital without delay. It is crucial to consult your healthcare provider if any new symptoms or abnormal reactions occur while taking this medication.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 64 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • back pain
  • cough
  • asthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • increased γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss
  • edema
  • thirst
  • facial edema
  • syncope

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a sealed container. Also, it is important to keep it at room temperature between 1°C and 30°C to maintain efficacy.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablets

Package unit

30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu * 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.